Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.

The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.

Sarkisyan G, Roberts AJ, Hedlund PB.

Behav Brain Res. 2010 May 1;209(1):99-108. doi: 10.1016/j.bbr.2010.01.022. Epub 2010 Jan 25.

2.

Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.

Bonaventure P, Kelly L, Aluisio L, Shelton J, Lord B, Galici R, Miller K, Atack J, Lovenberg TW, Dugovic C.

J Pharmacol Exp Ther. 2007 May;321(2):690-8. Epub 2007 Feb 21.

3.

Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.

Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E.

Eur J Pharmacol. 2004 Mar 8;487(1-3):133-42.

PMID:
15033385
4.

The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats.

Wesołowska A, Nikiforuk A.

Eur J Pharmacol. 2008 Mar 17;582(1-3):88-93. doi: 10.1016/j.ejphar.2007.12.013. Epub 2007 Dec 31.

PMID:
18234190
5.

Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.

Bourin M, Chenu F, Prica C, Hascoët M.

Psychopharmacology (Berl). 2009 Sep;206(1):97-107. doi: 10.1007/s00213-009-1583-7. Epub 2009 Jun 11.

PMID:
19517098
6.

Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice.

Wesołowska A, Tatarczyńska E, Nikiforuk A, Chojnacka-Wójcik E.

Eur J Pharmacol. 2007 Jan 19;555(1):43-7. Epub 2006 Oct 17.

PMID:
17109856
7.

Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.

Wesołowska A, Nikiforuk A.

Neuropharmacology. 2007 Apr;52(5):1274-83. Epub 2007 Jan 20.

PMID:
17320917
8.

The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.

Pałucha-Poniewiera A, Brański P, Lenda T, Pilc A.

J Pharmacol Exp Ther. 2010 Sep 1;334(3):1066-74. doi: 10.1124/jpet.110.169730. Epub 2010 Jun 18.

9.

Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.

Egashira N, Matsuda T, Koushi E, Higashihara F, Mishima K, Chidori S, Hasebe N, Iwasaki K, Nishimura R, Oishi R, Fujiwara M.

Eur J Pharmacol. 2008 Jul 28;589(1-3):117-21. doi: 10.1016/j.ejphar.2008.03.046. Epub 2008 Apr 8.

PMID:
18565508
10.

Antidepressant-like effects in various mice strains in the tail suspension test.

Ripoll N, David DJ, Dailly E, Hascoët M, Bourin M.

Behav Brain Res. 2003 Aug 14;143(2):193-200.

PMID:
12900045
11.

Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action.

Smolders I, Clinckers R, Meurs A, De Bundel D, Portelli J, Ebinger G, Michotte Y.

Neuropharmacology. 2008 May;54(6):1017-28. doi: 10.1016/j.neuropharm.2008.02.006. Epub 2008 Apr 1.

PMID:
18378264
12.

Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.

Takahashi E, Katayama M, Niimi K, Itakura C.

Eur J Pharmacol. 2008 Jul 28;589(1-3):149-56. doi: 10.1016/j.ejphar.2008.05.020. Epub 2008 May 23.

PMID:
18571641
13.

Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.

O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I.

Psychopharmacology (Berl). 2007 Jun;192(3):357-71. Epub 2007 Feb 21.

PMID:
17318507
14.

On the mechanism of antidepressant-like action of berberine chloride.

Kulkarni SK, Dhir A.

Eur J Pharmacol. 2008 Jul 28;589(1-3):163-72. doi: 10.1016/j.ejphar.2008.05.043. Epub 2008 Jun 3.

PMID:
18585703
15.

Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice.

Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I.

J Pharmacol Exp Ther. 2001 Sep;298(3):1101-7.

16.

Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.

Asaoka N, Nagayasu K, Nishitani N, Yamashiro M, Shirakawa H, Nakagawa T, Kaneko S.

Neuropharmacology. 2015 Aug;95:261-8. doi: 10.1016/j.neuropharm.2015.03.032. Epub 2015 Apr 8.

PMID:
25863120
17.
18.

Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems.

Dhir A, Kulkarni SK.

Can J Physiol Pharmacol. 2008 Oct;86(10):726-35. doi: 10.1139/y08-077.

PMID:
18841177
19.

The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation.

Pytka K, Walczak M, Kij A, Rapacz A, Siwek A, Kazek G, Olczyk A, Gałuszka A, Waszkielewicz A, Marona H, Sapa J, Filipek B.

Eur J Pharmacol. 2015 Oct 5;764:537-46. doi: 10.1016/j.ejphar.2015.07.041. Epub 2015 Jul 22.

PMID:
26210317
20.

Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system.

Freitas AE, Budni J, Lobato KR, Binfaré RW, Machado DG, Jacinto J, Veronezi PO, Pizzolatti MG, Rodrigues AL.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):335-43. doi: 10.1016/j.pnpbp.2009.12.010. Epub 2009 Dec 22.

PMID:
20026371

Supplemental Content

Support Center